Riskpilot← Back to searchSign inGet full accessClinicon AB
ABActiveOrg 5566332903BrommaManufacture of other technical ceramic products · NACE 2344Est. 20022 employees
Revenue 2024
SEK 5,5M
+48% vs 2023
EBITDA margin
40.8%
+90% vs 2023
Equity ratio
78.0%
Financial strength
Net profit 2024
SEK 950K
+890% vs 2023
| Revenue | SEK 5,5M | +48% |
| EBITDA | SEK 2,2M | +90% |
| Net profit | SEK 950K | +890% |
| Total assets | SEK 8,9M | +31% |
| Equity | SEK 6,9M | +16% |
| Employees | 2 | — |
Legal name
Clinicon AB
Org number
5566332903
Legal form
Aktiebolag
NACE code
2344 · Manufacture of other technical ceramic products
Founded
1 oktober 2002
Share capital
SEK 300 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva tillverkning, försäljning av laboratorie material samt service av analysutrustning, fordon och fastigheter ävensom idka därmed förenlig verksamhet.
Address
Bromma
Email
info@clinicon.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 5 142 | 4 000 | 3 574 | 3 699 | 5 466 |
| Staff expenses | — | — | −574 | — | −686 |
| EBITDA | 2 478 | 1 517 | 1 281 | 1 173 | 2 233 |
| Depreciation & amort. | −26 | −65 | −59 | −62 | −62 |
| EBIT | 2 452 | 1 452 | 1 221 | 1 111 | 2 170 |
| Net financials | −46 | — | 14 | 38 | 9 |
| Profit before tax | 1 681 | 903 | 115 | 121 | 1 200 |
| Tax | −366 | −189 | −24 | −25 | −249 |
| Net profit | 1 315 | 714 | 91 | 96 | 950 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 5 658 | 6 432 | 6 611 | 6 801 | 8 882 |
| Equity | 5 075 | 5 789 | 5 879 | 5 975 | 6 925 |
| Long-term debt | 0 | 0 | — | 0 | — |
| Short-term debt | 583 | 643 | 731 | 826 | 1 957 |
| Total debt | 583 | 643 | 731 | 826 | 1 957 |
EBITDA margin
40.8%
This company
15.8%
Market median
+158% vs market
20202024
Equity ratio
78.0%
This company
38.2%
Market median
+104% vs market
20202024
Return on equity
13.7%
This company
18.4%
Market median
+26% vs market
20202024
Net profit margin
17.4%
This company
8.1%
Market median
+115% vs market
20202024
Asset turnover
0.62×
This company
1.12×
Market median
-45% vs market
20202024
Debt / equity
0.28×
This company
0.62×
Market median
+55% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
EL | Audit | 2024 |
LP Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
BM | Audit | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Clinicon AB 
Borrby Frö AktiebolagBoard members of Clinicon AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Elias Lars Magnus Haraldsson | Audit | 0 companies |
| Lars Peter Degen | Chief Executive Officer | 0 companies |
| Barbro Margaretha Wikman | Audit | 0 companies |
| Oscar Fredrik Degen | Deputy Board Member | 0 companies |